J A Kemp is a leading firm of European Patent and Trade Mark Attorneys. We combine independent thinking with collective excellence in all that we do.
The technical and legal knowledge that we apply to the protection of our clients’ patents is outstanding in its breadth and depth. With around 100 science and technology graduates in the firm, including 50 PhDs, no area of science or technology is outside our scope. Our Patent Attorneys have collective in-depth expertise in patent law and procedure in every country of the world.
The team of professionals who advise our clients on trade mark and design matters have backgrounds in major international law firms and hold qualifications as Chartered UK Trade Mark Attorneys, Solicitors and European Trade Mark Professional Representatives. Dedicated to this specialist area of intellectual property protection, the team has the expertise and resources to protect trade marks and designs in any market worldwide.
Identifying different polymorphic forms of pharmaceutical
compounds is an important part of drug discovery and development.
There is a perception that it is difficult to secure patent
protection for new polymorphs. However, with careful drafting and
consideration of the specific advantages associated with the
polymorph of interest, patents directed to polymorphs of commercial
significance can be obtained. This webinar will discuss some of the
issues faced during the drafting and prosecution of patent
applications for polymorphs and how those issues can be
addressed.
Topics will include:
How to draft claims directed to polymorphs
Other drafting tips for polymorph applications
Establishing novelty and inventive step for polymorphs
Other issues to be aware of
This is a technical webinar aimed at:
In-house IP practitioners working in the drug development
field
Attorneys involved in drafting, prosecuting and advising on
patent claims for polymorphs which could be pursued in Europe
Practitioners having an interest in polymorphs and
pharmaceutical inventions
